Butane;ethane;7-methylsulfanyl-5-phenyl-3,4-dihydro-2H-1,5-benzothiazepin-8-ol
C22H33NOS2 — CID 156748661
Data last refreshed: (MolForge compound catalog, from PubChem)
About Butane;ethane;7-methylsulfanyl-5-phenyl-3,4-dihydro-2H-1,5-benzothiazepin-8-ol
Butane;ethane;7-methylsulfanyl-5-phenyl-3,4-dihydro-2H-1,5-benzothiazepin-8-ol (PubChem CID 156748661) has the molecular formula C22H33NOS2 and a molecular weight of 391.65 g/mol. Its IUPAC name is butane;ethane;7-methylsulfanyl-5-phenyl-3,4-dihydro-2H-1,5-benzothiazepin-8-ol.
Molecular Properties
| Compound Name | Butane;ethane;7-methylsulfanyl-5-phenyl-3,4-dihydro-2H-1,5-benzothiazepin-8-ol |
|---|---|
| PubChem CID | 156748661 |
| Molecular Formula | C22H33NOS2 |
| Molecular Weight | 391.65 g/mol |
| Exact Mass | 391.20 |
| IUPAC Name | butane;ethane;7-methylsulfanyl-5-phenyl-3,4-dihydro-2H-1,5-benzothiazepin-8-ol |
| SMILES | CC.CCCC.CSc1cc2c(cc1O)SCCCN2c1ccccc1 |
| InChI | InChI=1S/C16H17NOS2.C4H10.C2H6/c1-19-16-10-13-15(11-14(16)18)20-9-5-8-17(13)12-6-3-2-4-7-12;1-3-4-2;1-2/h2-4,6-7,10-11,18H,5,8-9H2,1H3;3-4H2,1-2H3;1-2H3 |
| InChIKey | SCDDANKJRRICLG-UHFFFAOYSA-N |
| XLogP | 7.58 |
| TPSA | 23.47 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 391.65 |
| LogP ≤ 5 | 7.58 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156748661 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.